China’s New mRNA Covid Vaccine Targeting Omicron Starts Trial Production

[ad_1] Chinese drugmaker CanSino Biologics started trial production of a vaccine using mRNA technology to target new variants of Covid-19 that are behind the country’s current outbreak. [ad_2] Source link

China to Allow Rapid Tests to Confirm Covid Cases

[ad_1] World Asia China Beijing takes more steps to dismantle its zero-Covid policies [ad_2] Source link

China-Developed mRNA Covid Vaccine Starts Test Production

[ad_1] Chinese drugmaker CanSino Biologics started trial production of a vaccine using mRNA Technology to target new variants of Covid-19 that are behind the country’s current outbreak. [ad_2] Source link